Your browser doesn't support javascript.
loading
Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial.
Byakika-Kibwika, Pauline; Sekaggya-Wiltshire, Christine; Semakula, Jerome Roy; Nakibuuka, Jane; Musaazi, Joseph; Kayima, James; Sendagire, Cornelius; Meya, David; Kirenga, Bruce; Nanzigu, Sarah; Kwizera, Arthur; Nakwagala, Fred; Kisuule, Ivan; Wayengera, Misaki; Mwebesa, Henry G; Kamya, Moses R; Bazeyo, William.
Afiliación
  • Byakika-Kibwika P; Department of Medicine, Makerere University College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda. pbyakika@gmail.com.
  • Sekaggya-Wiltshire C; Mulago National Referral Hospital, Kampala, Uganda.
  • Semakula JR; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Nakibuuka J; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Musaazi J; Mulago National Referral Hospital, Kampala, Uganda.
  • Kayima J; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Sendagire C; Department of Medicine, Makerere University College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
  • Meya D; Department of Anesthesia, Makerere University, Kampala, Uganda.
  • Kirenga B; Department of Medicine, Makerere University College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
  • Nanzigu S; Department of Medicine, Makerere University College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
  • Kwizera A; Makerere University Lung Institute, Kampala, Uganda.
  • Nakwagala F; Department of Pharmacology, Makerere University, Kampala, Uganda.
  • Kisuule I; Department of Anesthesia, Makerere University, Kampala, Uganda.
  • Wayengera M; Mulago National Referral Hospital, Kampala, Uganda.
  • Mwebesa HG; Mulago National Referral Hospital, Kampala, Uganda.
  • Kamya MR; Department of Microbiology, Makerere University, Kampala, Uganda.
  • Bazeyo W; Ministry of Health, Kampala, Uganda.
BMC Infect Dis ; 21(1): 1218, 2021 Dec 06.
Article en En | MEDLINE | ID: mdl-34872511
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Uganda
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Uganda